CNTB
Connect Biopharma·NASDAQ
--
--(--)
--
--(--)
CNTB fundamentals
Connect Biopharma (CNTB) released its earnings on Nov 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.3098 (YoY --), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.3098
--
Report date
Nov 12, 2025
EPS
Actual | -0.1888 | -0.3098 | |||||||
Forecast | -0.2597 | -0.2389 | |||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +27.30% | -29.68% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Connect Biopharma beat or miss consensus estimates last quarter?What guidance did Connect Biopharma's management provide for the next earnings period?What factors drove the changes in Connect Biopharma's revenue and profit?What is the revenue and EPS growth rate for Connect Biopharma year over year?What were the key takeaways from Connect Biopharma's earnings call?What is the market's earnings forecast for Connect Biopharma next quarter?What is Connect Biopharma's latest dividend and current dividend yield?What does Connect Biopharma do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
